𝛼SK or Search

ENTITY

Cargo Therapeutics (CRGX US)

2

Analysis

Health Care • United States

Cargo Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing chimeric antigen receptor (CAR) T-cell therapies for the treatment of cancer patients. Cargo Therapeutics serves customers in the United States.

more

Refresh

Exchange Announcement • 20 Aug 2025 04:32

S-3/A | Registration statement for specified transactions by certain issuers (Amendment)

Exchange Announcement • 20 Aug 2025 04:31

S-3/A | Registration statement for specified transactions by certain issuers (Amendment)

Exchange Announcement • 19 Aug 2025 21:54

Current Report (Form 8-K | Period ending 2025-08-18)

Exchange Announcement • 07 Aug 2025 04:05

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

Exchange Announcement • 08 Jul 2025 18:26

Current Report (Form 8-K | Period ending 2025-07-07)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x